The impairment of the anti-lipolytic action of insulin leads to increased lipolysis in adipocytes and increased circulating FFA, resulting in large amounts of FFA being sent to the liver and new lipogenesis, which in turn leads to steatosis and insulin resistance in muscle cells [39]. Here, INS is linked to steatosis.